(Q33397083)

26 July 2017

High pentraxin-3 plasma levels associate with thrombocytopenia in acute Puumala hantavirus-induced nephropathia epidemica (English)

1 reference

26 July 2017

1 reference

1 reference

nephropathia epidemica

1 reference

T K Outinen

1

1 reference

26 July 2017

S Mäkelä

2

1 reference

26 July 2017

H Huhtala

3

1 reference

26 July 2017

M Hurme

4

1 reference

26 July 2017

S Meri

5

1 reference

26 July 2017

I Pörsti

6

1 reference

26 July 2017

J Sane

7

1 reference

26 July 2017

A Vaheri

8

1 reference

26 July 2017

J Syrjänen

9

1 reference

26 July 2017

J Mustonen

10

1 reference

26 July 2017

7 September 2011

1 reference

European Journal of Clinical Microbiology & Infectious Diseases

26 July 2017

1 reference

26 July 2017

31

1 reference

26 July 2017

6

1 reference

26 July 2017

957-963

1 reference

https://scigraph.springernature.com/pub.10.1007/s10096-011-1392-x

26 July 2017

0 references

cites work

Hantavirus infections in Europe

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1392-X

Nephropathia Epidemica: Detection of Antigen in Bank Voles and Serologic Diagnosis of Human Infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1392-X

Pathogenesis of puumala and other hantavirus infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1392-X

Nephropathia epidemica in Finland: a retrospective study of 126 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1392-X

Disease burden of Puumala virus infections, 1995-2008.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1392-X

The severity of Puumala hantavirus induced nephropathia epidemica can be better evaluated using plasma interleukin-6 than C-reactive protein determinations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1392-X

High activity of indoleamine 2,3-dioxygenase is associated with renal insufficiency in Puumala hantavirus induced nephropathia epidemica

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1392-X

The long pentraxin PTX3 as a prototypic humoral pattern recognition receptor: interplay with cellular innate immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1392-X

Pentraxins in innate immunity: from C-reactive protein to the long pentraxin PTX3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1392-X

The long pentraxin PTX3 in vascular pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1392-X

The humoral pattern recognition receptor PTX3 is stored in neutrophil granules and localizes in extracellular traps

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1392-X

Pentraxins: multifunctional proteins at the interface of innate immunity and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1392-X

Multimer formation and ligand recognition by the long pentraxin PTX3. Similarities and differences with the short pentraxins C-reactive protein and serum amyloid P component.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1392-X

Binding of the long pentraxin PTX3 to factor H: interacting domains and function in the regulation of complement activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1392-X

Enhanced thrombin formation and fibrinolysis during acute Puumala hantavirus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1392-X

Urinary excretion of interleukin-6 correlates with proteinuria in acute Puumala hantavirus-induced nephritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1392-X

Monitoring tryptophan metabolism in chronic immune activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1392-X

High plasma level of long pentraxin 3 (PTX3) is associated with fatal disease in bacteremic patients: a prospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1392-X

Elevated plasma levels of the long pentraxin, pentraxin 3, in severe dengue virus infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1392-X

Pentraxins at the crossroads between innate immunity, inflammation, matrix deposition, and female fertility

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1392-X

Antiviral activity of the long chain pentraxin PTX3 against influenza viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1392-X

Long pentraxin PTX3 is associated with mortality and disease severity in severe Leptospirosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1392-X

IFN-gamma-inducible protein 10 and pentraxin 3 plasma levels are tools for monitoring inflammation and disease activity in Mycobacterium tuberculosis infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1392-X

Persisting high levels of plasma pentraxin 3 over the first days after severe sepsis and septic shock onset are associated with mortality.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1392-X

Circulating levels of the long pentraxin PTX3 correlate with severity of infection in critically ill patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1392-X

PTX3 predicts severe disease in febrile patients at the emergency department

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1392-X

Non-redundant role of the long pentraxin PTX3 in anti-fungal innate immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1392-X

Anti-Aspergillus fumigatus efficacy of pentraxin 3 alone and in combination with antifungals

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1392-X

Pentraxin 3 protects from MCMV infection and reactivation through TLR sensing pathways leading to IRF3 activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1392-X

PENTRAXIN 3 AND C-REACTIVE PROTEIN IN SEVERE MENINGOCOCCAL DISEASE

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1392-X

Platelet mediated complement activation

21 January 2018

1 reference

12 December 2020

Nephropathia epidemica in Finland. A clinical histological and epidemiological study

1 reference

12 December 2020

Mathematical tools for demonstrating the clinical usefulness of biochemical markers

1 reference

12 December 2020

Antigenic properties and diagnostic potential of puumala virus nucleocapsid protein expressed in insect cells.

1 reference

12 December 2020

More rapid method for simultaneous measurement of tryptophan and kynurenine by HPLC.

1 reference

12 December 2020

Complement activation in nephropathia epidemica caused by Puumala hantavirus

1 reference

12 December 2020

Complement activation in Puumala hantavirus infection correlates with disease severity

1 reference

12 December 2020

Clinical characteristics of nephropathia epidemica in Sweden: prospective study of 74 cases

1 reference

12 December 2020

10.1007/S10096-011-1392-X

Identifiers

DOI

1 reference

Dimensions Publication ID

26 July 2017

0 references

1 reference